rs78508822
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004813.4(PEX16):c.*159C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000603 in 1,611,214 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 3 hom. )
Consequence
PEX16
NM_004813.4 3_prime_UTR
NM_004813.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.378
Publications
0 publications found
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 8A (Zellweger)Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
- peroxisome biogenesis disorder 8BInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-45910095-G-A is Benign according to our data. Variant chr11-45910095-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1284823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00289 (440/152360) while in subpopulation AFR AF = 0.00986 (410/41588). AF 95% confidence interval is 0.00907. There are 3 homozygotes in GnomAd4. There are 204 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX16 | ENST00000241041.7 | c.1035C>T | p.His345His | synonymous_variant | Exon 11 of 11 | 1 | ENSP00000241041.3 | |||
PEX16 | ENST00000378750.10 | c.*159C>T | 3_prime_UTR_variant | Exon 11 of 11 | 1 | NM_004813.4 | ENSP00000368024.5 | |||
PEX16 | ENST00000532681.5 | c.*159C>T | downstream_gene_variant | 3 | ENSP00000434654.1 | |||||
PEX16 | ENST00000523721.2 | n.*75C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00288 AC: 438AN: 152242Hom.: 3 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
438
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000836 AC: 209AN: 250092 AF XY: 0.000561 show subpopulations
GnomAD2 exomes
AF:
AC:
209
AN:
250092
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000364 AC: 531AN: 1458854Hom.: 3 Cov.: 32 AF XY: 0.000339 AC XY: 246AN XY: 725758 show subpopulations
GnomAD4 exome
AF:
AC:
531
AN:
1458854
Hom.:
Cov.:
32
AF XY:
AC XY:
246
AN XY:
725758
show subpopulations
African (AFR)
AF:
AC:
297
AN:
33406
American (AMR)
AF:
AC:
53
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26122
East Asian (EAS)
AF:
AC:
0
AN:
39694
South Asian (SAS)
AF:
AC:
3
AN:
86164
European-Finnish (FIN)
AF:
AC:
0
AN:
52780
Middle Eastern (MID)
AF:
AC:
8
AN:
4146
European-Non Finnish (NFE)
AF:
AC:
96
AN:
1111618
Other (OTH)
AF:
AC:
74
AN:
60204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00289 AC: 440AN: 152360Hom.: 3 Cov.: 33 AF XY: 0.00274 AC XY: 204AN XY: 74506 show subpopulations
GnomAD4 genome
AF:
AC:
440
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
204
AN XY:
74506
show subpopulations
African (AFR)
AF:
AC:
410
AN:
41588
American (AMR)
AF:
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10
AN:
68038
Other (OTH)
AF:
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PEX16: BP4, BP7 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.